首页> 美国卫生研究院文献>other >A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery
【2h】

A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery

机译:恶性疟原虫传播阻断潜力的一组新的化学起点用于抗疟药物的发现

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The discovery of new antimalarials with transmission blocking activity remains a key issue in efforts to control malaria and eventually eradicate the disease. Recently, high-throughput screening (HTS) assays have been successfully applied to Plasmodium falciparum asexual stages to screen millions of compounds, with the identification of thousands of new active molecules, some of which are already in clinical phases. The same approach has now been applied to identify compounds that are active against P. falciparum gametocytes, the parasite stage responsible for transmission. This study reports screening results for the Tres Cantos Antimalarial Set (TCAMS), of approximately 13,533 molecules, against P. falciparum stage V gametocytes. Secondary confirmation and cytotoxicity assays led to the identification of 98 selective molecules with dual activity against gametocytes and asexual stages. Hit compounds were chemically clustered and analyzed for appropriate physicochemical properties. The TCAMS chemical space around the prioritized hits was also studied. A selection of hit compounds was assessed ex vivo in the standard membrane feeding assay and demonstrated complete block in transmission. As a result of this effort, new chemical structures not connected to previously described antimalarials have been identified. This new set of compounds may serve as starting points for future drug discovery programs as well as tool compounds for identifying new modes of action involved in malaria transmission.
机译:发现具有传播阻断活性的新抗疟药仍然是控制疟疾并最终根除该疾病的努力中的关键问题。最近,高通量筛选(HTS)分析已成功应用于恶性疟原虫的无性阶段,以筛选数百万种化合物,并鉴定了成千上万个新的活性分子,其中一些已经处于临床阶段。现在已经采用了相同的方法来鉴定对恶性疟原虫配子细胞(负责传播的寄生虫阶段)具有活性的化合物。这项研究报告了针对恶性疟原虫V期配子细胞的Tres Cantos抗疟疾套装(TCAMS)约13,533个分子的筛选结果。二次确认和细胞毒性分析导致鉴定出对配子细胞和无性阶段具有双重活性的98个选择性分子。对命中的化合物进行化学聚类,并分析其适当的理化性质。还研究了优先命中周围的TCAMS化学空间。在标准的膜进料试验中对离体化合物的选择进行了离体评估,并证明了完全阻断了传播。由于这一努力,已经发现了与先前描述的抗疟疾药物不相关的新化学结构。这套新化合物可作为未来药物开发计划的起点,也可作为鉴定与疟疾传播有关的新作用方式的工具化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号